Italy: Kedrion and BPL merge to create global player in human blood plasma medicines

Funds advised by PE firm Permira, supported by their co-investor, a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA), have entered into a partnership with Kedrion’s existing shareholders (the Marcucci family and FSI) to jointly acquire and combine Kedrion and BPL. The combination will create a global player for medicines derived from human…

You must be a HMI Subscriber to view this content.

Subscribe Now »